NYSE:ASPN

Aspen Aerogels Stock Forecast, Price & News

$44.22
-1.19 (-2.62 %)
(As of 09/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$43.73
$45.79
50-Day Range
$30.91
$46.19
52-Week Range
$9.24
$46.79
Volume157,172 shs
Average Volume256,756 shs
Market Capitalization$1.46 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.5
30 days | 90 days | 365 days | Advanced Chart
Receive ASPN News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Aerogels and its competitors with MarketBeat's FREE daily newsletter.


Aspen Aerogels logo

About Aspen Aerogels

Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee on May 4, 2001 and is headquartered in Northborough, MA.

Headlines

What 5 Analyst Ratings Have To Say About Aspen Aerogels
What 5 Analyst Ratings Have To Say About Aspen Aerogels
September 10, 2021 |  markets.businessinsider.com
Aspen Aerogels (NYSE:ASPN) Shares Gap Up to $41.99
Aspen Aerogels (NYSE:ASPN) Shares Gap Up to $41.99
September 10, 2021 |  americanbankingnews.com
Aspen Aerogels (NYSE:ASPN) Now Covered by Piper Sandler
Aspen Aerogels (NYSE:ASPN) Now Covered by Piper Sandler
September 9, 2021 |  americanbankingnews.com
Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year High at $45.35
Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year High at $45.35
August 30, 2021 |  americanbankingnews.com
Aspen Aerogels (NYSE:ASPN) Shares Gap Up to $42.17
Aspen Aerogels (NYSE:ASPN) Shares Gap Up to $42.17
August 25, 2021 |  americanbankingnews.com
Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year High at $42.06
Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year High at $42.06
August 23, 2021 |  americanbankingnews.com
VIEW, ASPN among industrial movers
VIEW, ASPN among industrial movers
August 23, 2021 |  seekingalpha.com
Recap: Aspen Aerogels Q2 Earnings
Recap: Aspen Aerogels Q2 Earnings
July 29, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.20 out of 5 stars

Construction Sector

61st out of 137 stocks

Lumber & Other Construction Materials Industry

2nd out of 7 stocks

Analyst Opinion: 2.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Aspen Aerogels (NYSE:ASPN) Frequently Asked Questions

Is Aspen Aerogels a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Aerogels in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aspen Aerogels stock.
View analyst ratings for Aspen Aerogels
or view top-rated stocks.

What stocks does MarketBeat like better than Aspen Aerogels?

Wall Street analysts have given Aspen Aerogels a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aspen Aerogels wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aspen Aerogels?

Aspen Aerogels saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 510,900 shares, a drop of 28.7% from the August 15th total of 716,600 shares. Based on an average daily volume of 273,400 shares, the days-to-cover ratio is currently 1.9 days.
View Aspen Aerogels' Short Interest
.

When is Aspen Aerogels' next earnings date?

Aspen Aerogels is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Aspen Aerogels
.

How were Aspen Aerogels' earnings last quarter?

Aspen Aerogels, Inc. (NYSE:ASPN) posted its quarterly earnings results on Wednesday, July, 28th. The construction company reported ($0.23) EPS for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.04. The construction company had revenue of $31.67 million for the quarter, compared to analysts' expectations of $25.35 million. Aspen Aerogels had a negative net margin of 24.17% and a negative trailing twelve-month return on equity of 30.20%.
View Aspen Aerogels' earnings history
.

How has Aspen Aerogels' stock been impacted by Coronavirus?

Aspen Aerogels' stock was trading at $6.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ASPN stock has increased by 580.3% and is now trading at $44.22.
View which stocks have been most impacted by COVID-19
.

What guidance has Aspen Aerogels issued on next quarter's earnings?

Aspen Aerogels issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $-1.040-$-0.940 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-1.010. The company issued revenue guidance of $110 million-$118 million, compared to the consensus revenue estimate of $109.37 million.

What price target have analysts set for ASPN?

8 analysts have issued 12 month price targets for Aspen Aerogels' stock. Their forecasts range from $37.81 to $58.00. On average, they anticipate Aspen Aerogels' share price to reach $46.69 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price.
View analysts' price targets for Aspen Aerogels
or view top-rated stocks among Wall Street analysts.

Who are Aspen Aerogels' key executives?

Aspen Aerogels' management team includes the following people:
  • Donald R. Young, President, Chief Executive Officer & Director
  • Gregg R. Landes, Senior VP-Operations & Strategic Development
  • John F. Fairbanks, Chief Financial Officer, Treasurer & VP
  • George L. Gould, Chief Technology Officer
  • Corby C. Whitaker, Senior Vice President-Sales & Marketing

What is Donald R. Young's approval rating as Aspen Aerogels' CEO?

5 employees have rated Aspen Aerogels CEO Donald R. Young on Glassdoor.com. Donald R. Young has an approval rating of 100% among Aspen Aerogels' employees. This puts Donald R. Young in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Aspen Aerogels' key competitors?

What other stocks do shareholders of Aspen Aerogels own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Aerogels investors own include Intelsat (I), Gilead Sciences (GILD), Bank of America (BAC), AMC Entertainment (AMC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), China Unicom (Hong Kong) (CHU) and Ciena (CIEN).

What is Aspen Aerogels' stock symbol?

Aspen Aerogels trades on the New York Stock Exchange (NYSE) under the ticker symbol "ASPN."

Who are Aspen Aerogels' major shareholders?

Aspen Aerogels' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Jefferies Group LLC (0.00%), Spring Creek Capital LLC (10.51%), BlackRock Inc. (4.78%), Vanguard Group Inc. (3.96%), State Street Corp (2.24%) and Next Century Growth Investors LLC (1.81%). Company insiders that own Aspen Aerogels stock include Corby C Whitaker and Kelley Conte.
View institutional ownership trends for Aspen Aerogels
.

Which major investors are selling Aspen Aerogels stock?

ASPN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Morgan Stanley, Renaissance Technologies LLC, EAM Investors LLC, Roubaix Capital LLC, Price T Rowe Associates Inc. MD, and EAM Global Investors LLC. Company insiders that have sold Aspen Aerogels company stock in the last year include Corby C Whitaker, and Kelley Conte.
View insider buying and selling activity for Aspen Aerogels
or view top insider-selling stocks.

Which major investors are buying Aspen Aerogels stock?

ASPN stock was acquired by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Spring Creek Capital LLC, Cowen Prime Advisors LLC, Millennium Management LLC, RK Capital Management LLC, State Street Corp, Point72 Asset Management L.P., and Vanguard Group Inc..
View insider buying and selling activity for Aspen Aerogels
or or view top insider-buying stocks.

How do I buy shares of Aspen Aerogels?

Shares of ASPN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Aerogels' stock price today?

One share of ASPN stock can currently be purchased for approximately $44.22.

How much money does Aspen Aerogels make?

Aspen Aerogels has a market capitalization of $1.46 billion and generates $100.27 million in revenue each year. The construction company earns $-21,810,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does Aspen Aerogels have?

Aspen Aerogels employs 290 workers across the globe.

What is Aspen Aerogels' official website?

The official website for Aspen Aerogels is www.aerogel.com.

Where are Aspen Aerogels' headquarters?

Aspen Aerogels is headquartered at 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532.

How can I contact Aspen Aerogels?

Aspen Aerogels' mailing address is 30 FORBES ROAD BUILDING B, NORTHBOROUGH MA, 01532. The construction company can be reached via phone at (508) 691-1111 or via email at [email protected]


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.